Targeted next-generation sequencing in family with an occurrence of neurodevelopmental disorders and epilepsy
Ontology highlight
ABSTRACT: We performed a targeted NGS using the commercial gene panel design ClearSeq Inherited Disease (Agilent Technologies) to identify the pathogenic sequence variants in two boys with neurodevelopmental disorders and epilepsy and their unaffected parents
INSTRUMENT(S): NextSeq 500
ORGANISM(S): Homo sapiens
SUBMITTER: Marketa Wayhelova
PROVIDER: E-MTAB-8131 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA